Charlene Bush-Donovan

Title: Charlene Bush-Donovan: Innovator in Nucleic Acid Detection

Introduction

Charlene Bush-Donovan is a prominent inventor based in Livermore, CA (US). She has made significant contributions to the field of molecular diagnostics, particularly in the detection of influenza viruses and gonococcal infections. With a total of 2 patents, her work has advanced the capabilities of nucleic acid amplification methods.

Latest Patents

One of her latest patents focuses on "Nucleic acid primers and probes for detecting human and avian influenza viruses." This invention provides nucleic acid sequences that are utilized to prepare primers and probes for a kinetic polymerase chain reaction (kPCR) assay. The assay is designed to detect influenza viruses in both human and animal subjects. The primers and probes are effective for detecting type A and type B influenza viruses, including all known INFA subtypes such as H1, H2, H3, H4, H5, H6, H7, H8, and H9. Another patent relates to oligonucleotide sequences for amplification primers and detection probes, which are used in nucleic acid amplification methods for the selective detection of biological samples.

Career Highlights

Charlene is currently associated with Siemens Healthcare Diagnostics GmbH, where she continues to innovate in the field of healthcare diagnostics. Her work has been instrumental in developing tools that enhance the accuracy and efficiency of disease detection.

Collaborations

Charlene has collaborated with notable colleagues, including Lailing Ku and David Sherman, to further her research and development efforts in molecular diagnostics.

Conclusion

Charlene Bush-Donovan's contributions to the field of nucleic acid detection have made a significant impact on healthcare diagnostics. Her innovative patents and collaborations reflect her commitment to advancing medical technology.